Genomic Medicine Institute Adds Seven Additional Illumina, Inc. Genome Analyzers to Expand Capacity for Asian 100 Genome Project

SEOUL, Korea--(BUSINESS WIRE)--Illumina (NASDAQ:ILMN) today announced that the Genomic Medicine Institute (GMI) at Seoul National University College of Medicine in Korea, purchased seven additional Illumina Genome AnalyzerIIx sequencing systems, expanding the capacity of their recently established Asian Genome Center to 10 Illumina sequencing systems.